https://publications-cnrc.canada.ca/fra/voir/objet/?id=fc78cb22-41a7-467c-a740-a20f5da1e7d5
Expert Opinion on Drug Metabolism & Toxicology, Taylor & Francis, 2 novembre 2021, Volume : 17, Numéro : 11
Antisense oligonucleotides (ASOs) have emerged as a promising novel drug modality that aims to address unmet medical needs. A record of six ASO drugs have been...
Article de périodique (revue)
Texte intégral en ligne